BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012;72:1645-1669. [PMID: 22867045 DOI: 10.2165/11635500-000000000-00000] [Cited by in Crossref: 95] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014;29:1356-1360. [PMID: 24548074 DOI: 10.1111/jgh.12560] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
2 Bui K, She F, Sostek M. The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol. J Clin Pharmacol 2014;54:1368-74. [PMID: 24945932 DOI: 10.1002/jcph.348] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
3 Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesthesia & Analgesia 2017;124:44-51. [DOI: 10.1213/ane.0000000000001683] [Cited by in Crossref: 135] [Cited by in F6Publishing: 42] [Article Influence: 27.0] [Reference Citation Analysis]
4 Heyn J, Azad SC. Differenzialindikation von Opioiden in der Schmerztherapie. Anaesthesist 2017;66:829-39. [DOI: 10.1007/s00101-017-0369-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Cote DJ, Burke WT, Castlen JP, King CH, Zaidi HA, Smith TR, Laws ER, Aglio LS. Safety of remifentanil in transsphenoidal surgery: A single-center analysis of 540 patients. J Clin Neurosci 2017;38:96-9. [PMID: 28110927 DOI: 10.1016/j.jocn.2016.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Rotundo L, Pyrsopoulos N. Liver injury induced by paracetamol and challenges associated with intentional and unintentional use. World J Hepatol 2020; 12(4): 125-136 [PMID: 32685105 DOI: 10.4254/wjh.v12.i4.125] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
7 Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging 2013;8:37-46. [PMID: 23355774 DOI: 10.2147/CIA.S30165] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
8 Ibrahim NM, Abdelhameed KM, Kamal SMM, Khedr EMH, Kotb HIM. Effect of Transcranial Direct Current Stimulation of the Motor Cortex on Visceral Pain in Patients with Hepatocellular Carcinoma. Pain Med 2018;19:550-60. [PMID: 28605527 DOI: 10.1093/pm/pnx087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Lubel JS, Roberts SK, Strasser SI, Thompson AJ, Philip J, Goodwin M, Clarke S, Crawford DH, Levy MT, Shackel N. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement. Med J Aust 2021;214:475-83. [PMID: 33314233 DOI: 10.5694/mja2.50885] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ao Z, Cai H, Wu Z, Krzesniak J, Tian C, Lai YY, Mackie K, Guo F. Human Spinal Organoid-on-a-Chip to Model Nociceptive Circuitry for Pain Therapeutics Discovery. Anal Chem 2021. [PMID: 34928595 DOI: 10.1021/acs.analchem.1c04641] [Reference Citation Analysis]
11 Zhuo J, Zheng Y, Hu W, Yin G. Sufentanil Inhibits Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells by Upregulating miRNA-204. j biomater tissue eng 2021;11:718-24. [DOI: 10.1166/jbt.2021.2561] [Reference Citation Analysis]
12 Dureja GP, Iyer RN, Das G, Ahdal J, Narang P. Evidence and consensus recommendations for the pharmacological management of pain in India. J Pain Res 2017;10:709-36. [PMID: 28435313 DOI: 10.2147/JPR.S128655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Khorablou Z, Shahdost-Fard F, Razmi H. Voltammetric determination of pethidine in biofluids at a carbon cloth electrode modified by carbon selenide nanofilm. Talanta 2021;239:123131. [PMID: 34920261 DOI: 10.1016/j.talanta.2021.123131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Quandt J. Anesthetic Considerations for Hepatic Disease. In: Smith LJ, editor. Questions and Answers in Small Animal Anesthesia. Hoboken: John Wiley & Sons, Inc; 2015. pp. 269-74. [DOI: 10.1002/9781118912997.ch34] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Klinge M, Coppler T, Liebschutz JM, Dugum M, Wassan A, DiMartini A, Rogal S. The assessment and management of pain in cirrhosis. Curr Hepatol Rep 2018;17:42-51. [PMID: 29552453 DOI: 10.1007/s11901-018-0389-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
16 Matar KM, Tayem YI. Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats. Biomed Res Int 2014;2014:570910. [PMID: 25009818 DOI: 10.1155/2014/570910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Wilcock A, Charlesworth S, Prentice W, Selby P, Mckenna M, Cripps S, Considine A, Orr A, Wright M, Mihalyo M, Oxberry S. Prescribing in Chronic Severe Hepatic Impairment. Journal of Pain and Symptom Management 2019;58:515-37. [DOI: 10.1016/j.jpainsymman.2019.04.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
18 Bloom A, Mudiyansalage VW, Rhodes A, Hogg M, Jayasekera C, Gorelik A, Sood S, Nicoll A. Can adequate analgesia be achieved in patients with cirrhosis without precipitating hepatic encephalopathy? A prospective study. Clin Exp Hepatol 2020;6:243-52. [PMID: 33145431 DOI: 10.5114/ceh.2020.99521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kress HG, Coluzzi F. Tapentadol in the management of cancer pain: current evidence and future perspectives. J Pain Res 2019;12:1553-60. [PMID: 31190966 DOI: 10.2147/JPR.S191543] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Dalal AR. Split liver transplantation: What’s unique? World J Transplant 2015; 5(3): 89-94 [PMID: 26421261 DOI: 10.5500/wjt.v5.i3.89] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Oh J, Lee S, Kim A, Yoon J, Jang K, Lee DH, Cho S, Lee SR, Yu KS, Chung JY. Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study. J Clin Pharmacol 2018;58:64-73. [PMID: 28815639 DOI: 10.1002/jcph.973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Mao W, Wei XQ, Tao J, Zhen FP, Wen ZF, Wu B. The safety of combined sedation with propofol plus fentanyl for endoscopy screening and endoscopic variceal ligation in cirrhotic patients. J Dig Dis 2014;15:124-30. [PMID: 24224839 DOI: 10.1111/1751-2980.12115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Winhusen T, Theobald J, Lewis D, Wilder CM, Lyons MS. Development and initial testing of a tailored telephone intervention delivered by peers to prevent recurring opioid-overdoses (TTIP-PRO). Health Educ Res 2016;31:146-60. [PMID: 27004905 DOI: 10.1093/her/cyw010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
24 Zeien J, Qiu W, Triay M, Dhaibar HA, Cruz-Topete D, Cornett EM, Urits I, Viswanath O, Kaye AD. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed Pharmacother 2021;146:112503. [PMID: 34922113 DOI: 10.1016/j.biopha.2021.112503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 O'Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, Mikus G, Morlion BJ, Perez-Cajaraville J, Pogatzki-Zahn E, Varrassi G, Wells JC. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21:3-19. [PMID: 27991730 DOI: 10.1002/ejp.970] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 25.3] [Reference Citation Analysis]
26 Yamamoto N, Yamashita Y, Yoshiga D, Ishikawa A, Matsuo K, Miyamoto I, Oda M, Tanaka T, Kito S, Seta Y, Takahashi T, Koga H, Kawano K, Morimoto Y. Occurrence of silk stitch abscess after surgery in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2013;18:e701-5. [PMID: 23722129 DOI: 10.4317/medoral.18792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Alchin J, Dhar A, Siddiqui K, Christo PJ. Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older. Curr Med Res Opin 2022;:1-36. [PMID: 35253560 DOI: 10.1080/03007995.2022.2049551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Alkharfy KM, Ali FA, Alkharfy MA, Jan BL, Raish M, Alqahtani S, Ahmad A. Effect of compromised liver function and acute kidney injury on the pharmacokinetics of thymoquinone in a rat model. Xenobiotica 2020;50:858-62. [PMID: 32216504 DOI: 10.1080/00498254.2020.1745319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Perri GA, Yeung H, Green Y, Bezant A, Lee C, Berall A, Karuza J, Khosravani H. A Survey of Knowledge and Attitudes of Nurses About Pain Management in End-Stage Liver Disease in a Geriatric Palliative Care Unit. Am J Hosp Palliat Care 2018;35:92-9. [PMID: 28256899 DOI: 10.1177/1049909116684765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Stein C, Kopf A. Pain therapy - Are there new options on the horizon? Best Pract Res Clin Rheumatol 2019;33:101420. [PMID: 31703793 DOI: 10.1016/j.berh.2019.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
31 Ojeda A, Moreno LA. Pain management in patients with liver cirrhosis. Gastroenterol Hepatol. 2014;37:35-45. [PMID: 24309482 DOI: 10.1016/j.gastrohep.2013.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, Alavian SM. The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review Article. Anesth Pain Med 2016;6:e37822. [PMID: 27843779 DOI: 10.5812/aapm.37822] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Wu G, Zhang L, Wang X, Yu A, Zhang Z, Yu J. Effects of indexes of consciousness (IoC1 and IoC2) monitoring on remifentanil dosage in modified radical mastectomy: a randomized trial. Trials 2016;17:167. [PMID: 27026012 DOI: 10.1186/s13063-016-1298-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
34 Lux D, Naito A, Harikrishnan S. Congenital extrahepatic portosystemic shunt with progressive myelopathy and encephalopathy. Pract Neurol 2019;19:368-71. [PMID: 31048365 DOI: 10.1136/practneurol-2018-002111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
35 Garrett J, Vanston A, Ogola G, da Graca B, Cassity C, Kouznetsova MA, Hall LR, Qiu T. Predicting opioid-induced oversedation in hospitalised patients: a multicentre observational study. BMJ Open 2021;11:e051663. [PMID: 34819283 DOI: 10.1136/bmjopen-2021-051663] [Reference Citation Analysis]
36 Shahinfard H, Shabani-Nooshabadi M, Reisi-Vanani A, Ansarinejad H. A novel platform based on CoMn2O4-rGO/1-ethyl-3-methylimidazolium chloride modified carbon paste electrode for voltammetric detection of pethidine in the presence morphine and olanzapine. Chemosphere 2022;:134710. [PMID: 35487358 DOI: 10.1016/j.chemosphere.2022.134710] [Reference Citation Analysis]
37 Arafa MH, Atteia HH. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity. Toxicology and Applied Pharmacology 2018;346:37-44. [DOI: 10.1016/j.taap.2018.03.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
38 Khandelwal A, Gupta S, Singh GP, Chaturvedi A. Persistent low bispectral index values with propofol in a patient of cirrhosis. J Anaesthesiol Clin Pharmacol 2021;37:137-9. [PMID: 34103845 DOI: 10.4103/joacp.JOACP_277_18] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Stewart D, Kinsella J, McPeake J, Quasim T, Puxty A. The influence of alcohol abuse on agitation, delirium and sedative requirements of patients admitted to a general intensive care unit. J Intensive Care Soc 2019;20:208-15. [PMID: 31447913 DOI: 10.1177/1751143718787748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, Kanwal F. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022. [PMID: 35103995 DOI: 10.1002/hep.32378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon 2016;16:e32636. [PMID: 27257423 DOI: 10.5812/hepatmon.32636] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
42 Curseen KA, Taj J, Grant Q. Pain Management in Patients with Serious Illness. Med Clin North Am 2020;104:415-38. [PMID: 32312407 DOI: 10.1016/j.mcna.2020.01.005] [Reference Citation Analysis]
43 Kumar B, Modi M, Saikia B, Medhi B. Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence. ACS Chem Neurosci 2017;8:1589-97. [PMID: 28324653 DOI: 10.1021/acschemneuro.7b00084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
44 Vaja R, Rana M. Drugs and the liver. Anaesthesia & Intensive Care Medicine 2020;21:517-23. [DOI: 10.1016/j.mpaic.2020.07.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Hansen JD, Perri RE, Riess ML. Liver and Biliary Disease of Pregnancy and Anesthetic Implications: A Review. Anesth Analg 2021;133:80-92. [PMID: 33687174 DOI: 10.1213/ANE.0000000000005433] [Reference Citation Analysis]
46 Dalal A. Anesthesia for liver transplantation. Transplantation Reviews 2016;30:51-60. [DOI: 10.1016/j.trre.2015.05.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
47 Hayward KL, Weersink RA. Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatol Commun 2020;4:1562-77. [PMID: 33163829 DOI: 10.1002/hep4.1612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, Ohldieck C, Druckrey-Fiskaaen KT, Aas C, Løberg EM, Bramness JG, Fadnes LT. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. J Addict Dis 2022;:1-11. [PMID: 35356868 DOI: 10.1080/10550887.2022.2057140] [Reference Citation Analysis]
49 García-Cortés M, García-García A. Management of Pharmacologic Adverse Effects in Advanced Liver Disease. Clin Drug Investig 2022. [PMID: 35522395 DOI: 10.1007/s40261-022-01150-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Huang AR, Mallet L. Prescribing opioids in older people. Maturitas 2013;74:123-9. [PMID: 23201325 DOI: 10.1016/j.maturitas.2012.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
51 Kul A, Ozdemir M, Sagirli O. Determination of pethidine of abuse and relevant metabolite norpethidine in urine by ultra-performance liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2020;186:113320. [PMID: 32387748 DOI: 10.1016/j.jpba.2020.113320] [Reference Citation Analysis]
52 Roulet L, Rollason V, Desmeules J, Piguet V. Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients. Drugs 2021;81:1257-72. [PMID: 34196947 DOI: 10.1007/s40265-021-01515-z] [Reference Citation Analysis]
53 Ostroumova OD, Pereverzev AP. Hepatic impairment as a risk factor of adverse drug reactions. Consilium Medicum 2021;23:939-48. [DOI: 10.26442/20751753.2021.12.201234] [Reference Citation Analysis]
54 Gallagher J, Biesboer AN, Killian AJ. Pharmacologic Issues in Liver Disease. Critical Care Clinics 2016;32:397-410. [DOI: 10.1016/j.ccc.2016.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
55 Yogaratnam D, Ditch K, Medeiros K, Miller MA, Smith BS. The Impact of Liver and Renal Dysfunction on the Pharmacokinetics and Pharmacodynamics of Sedative and Analgesic Drugs in Critically Ill Adult Patients. Crit Care Nurs Clin North Am 2016;28:183-94. [PMID: 27215356 DOI: 10.1016/j.cnc.2016.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182-236. [PMID: 29628281 DOI: 10.1016/j.jhep.2018.03.019] [Cited by in Crossref: 2122] [Cited by in F6Publishing: 1974] [Article Influence: 530.5] [Reference Citation Analysis]
57 Hughes LT, Raftery D, Coulter P, Laird B, Fallon M. Use of opioids in patients with cancer with hepatic impairment-a systematic review. BMJ Support Palliat Care 2021:bmjspcare-2021-003065. [PMID: 34470772 DOI: 10.1136/bmjspcare-2021-003065] [Reference Citation Analysis]
58 Kreher M. Symptom Control at the End of Life. Med Clin North Am 2016;100:1111-22. [PMID: 27542430 DOI: 10.1016/j.mcna.2016.04.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther. 2013;37:1132-1156. [PMID: 23638982 DOI: 10.1111/apt.12324] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
60 Rakoski M, Goyal P, Spencer-Safier M, Weissman J, Mohr G, Volk M. Pain management in patients with cirrhosis. Clin Liver Dis (Hoboken) 2018;11:135-40. [PMID: 30992804 DOI: 10.1002/cld.711] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
61 Fukumura K, Yamada T, Yokota T, Kawasaki A. The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Naldemedine. Clin Pharmacol Drug Dev 2020;9:162-74. [PMID: 30977959 DOI: 10.1002/cpdd.690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
62 Weibel S, Jelting Y, Afshari A, Pace NL, Eberhart LH, Jokinen J, Artmann T, Kranke P. Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour. Cochrane Database Syst Rev 2017;4:CD011989. [PMID: 28407220 DOI: 10.1002/14651858.CD011989.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Marsousi N, Desmeules JA, Rudaz S, Daali Y. Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine. Journal of Pharmaceutical Sciences 2017;106:2380-91. [DOI: 10.1016/j.xphs.2017.04.035] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
64 Shah K, Stout B, Caskey H. Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials. Cureus 2020;12:e9128. [PMID: 32789069 DOI: 10.7759/cureus.9128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Choi L, Ferrell BA, Vasilevskis EE, Pandharipande PP, Heltsley R, Ely EW, Stein CM, Girard TD. Population Pharmacokinetics of Fentanyl in the Critically Ill. Crit Care Med 2016;44:64-72. [PMID: 26491862 DOI: 10.1097/CCM.0000000000001347] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
66 Walko CM, McLeod HL. Personalizing medicine in geriatric oncology. J Clin Oncol 2014;32:2581-6. [PMID: 25071134 DOI: 10.1200/JCO.2014.55.9047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
67 Roa JA, Guevara A, Guevara C, Guevara-Aguirre J. Physician's role in prescribing opioids in developing countries. BMJ Case Rep 2019;12:e227072. [PMID: 31160299 DOI: 10.1136/bcr-2018-227072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Jia Y, Wang Z, Fang D, Yang B, Li R, Liu Y. Acetaminophen promotes horizontal transfer of plasmid-borne multiple antibiotic resistance genes. Science of The Total Environment 2021;782:146916. [DOI: 10.1016/j.scitotenv.2021.146916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman PR, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts MF, Alford DP, Starrels JL, Chandler RK. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend 2020;217:108325. [PMID: 33091842 DOI: 10.1016/j.drugalcdep.2020.108325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
70 Choi H, Radparvar S, Aitken SL, Altshuler J. Analgosedation: The Use of Fentanyl Compared to Hydromorphone. J Crit Care Med (Targu Mures) 2021;7:192-8. [PMID: 34722922 DOI: 10.2478/jccm-2021-0026] [Reference Citation Analysis]
71 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications. Clin Mol Hepatol 2018;24:230-77. [PMID: 29991196 DOI: 10.3350/cmh.2018.1005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
72 Nada EM, Alabdulkareem A. Morphine versus fentanyl patient-controlled analgesia for postoperative pain control in major hepatic resection surgeries including living liver donors: A retrospective study. Saudi J Anaesth 2018;12:250-5. [PMID: 29628836 DOI: 10.4103/sja.SJA_625_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Roy DN, Goswami R. Drugs of abuse and addiction: A slippery slope toward liver injury. Chem Biol Interact. 2016;255:92-105. [PMID: 26409324 DOI: 10.1016/j.cbi.2015.09.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
74 Wu G, Fu G, Zhang L, Zhang Z, Wang X. Effects of neoadjuvant chemotherapy on the depth of total intravenous anesthesia in patients with breast cancer undergoing unilateral modified radical mastectomy: A prospective observational study. Medicine (Baltimore) 2018;97:e13776. [PMID: 30572532 DOI: 10.1097/MD.0000000000013776] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 2018;15:168-80. [PMID: 29139482 DOI: 10.1038/nrgastro.2017.141] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 12.4] [Reference Citation Analysis]
76 Doostmohammadi M, Rahimi HR. ADME and toxicity considerations for tramadol: from basic research to clinical implications. Expert Opin Drug Metab Toxicol 2020;16:627-40. [PMID: 32476523 DOI: 10.1080/17425255.2020.1776700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
77 Chagas AL, Mattos AA, Carrilho FJ, Bittencourt PL, Vezozzo DCP, Horvat N, Rocha MS, Alves VAF, Coral GP, Alvares-DA-Silva MR, Barros FMDR, Menezes MR, Monsignore LM, Coelho FF, Silva RFD, Silva RCMA, Boin IFSF, D Albuquerque LAC, Garcia JHP, Felga GEG, Moreira AM, Braghiroli MIFM, Hoff PMG, Mello VB, Dottori MF, Branco TP, Schiavon LL, Costa TFA; Members of the Panel of the 2nd Consensus of the Brazilian Society of Hepatology on the Diagnosis and Management of Hepatocellular Carcinoma. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA. Arq Gastroenterol 2020;57:1-20. [PMID: 32294682 DOI: 10.1590/S0004-2803.202000000-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
78 Gonzalez M, Goracci L, Cruciani G, Poggesi I. Some considerations on the predictions of pharmacokinetic alterations in subjects with liver disease. Expert Opinion on Drug Metabolism & Toxicology 2014;10:1397-408. [DOI: 10.1517/17425255.2014.952628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
79 Beaudoin FL, Merchant RC, Janicki A, McKaig DM, Babu KM. Preventing iatrogenic overdose: a review of in-emergency department opioid-related adverse drug events and medication errors. Ann Emerg Med 2015;65:423-31. [PMID: 25534653 DOI: 10.1016/j.annemergmed.2014.11.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
80 Liu XY, Zhang YB, Yang XW, Xu W, Liu L, Zhang P, Gong Y, Liu NF, Peng KF. Simultaneous determination of twenty-five compounds with anti-inflammatory activity in Spatholobi Caulis by using an optimized UFLC-MS/MS method: An application to pharmacokinetic study. J Pharm Biomed Anal 2021;204:114267. [PMID: 34303214 DOI: 10.1016/j.jpba.2021.114267] [Reference Citation Analysis]
81 Camboni-Schellenberg EL, Sinner B. [Anesthesia with liver failure]. Anaesthesist 2016;65:77-94. [PMID: 26727937 DOI: 10.1007/s00101-015-0094-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Sheikh F, Brandt N, Vinh D, Elon RD. Management of Chronic Pain in Nursing Homes: Navigating Challenges to Improve Person-Centered Care. J Am Med Dir Assoc 2021;22:1199-205. [PMID: 33497656 DOI: 10.1016/j.jamda.2020.12.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sommerfeld-Klatta K, Łukasik-Głębocka M, Zielińska-Psuja B. Oxidative stress and biochemical indicators in blood of patients addicted to alcohol treated for acute ethylene glycol poisoning. Hum Exp Toxicol 2022;41:9603271211061502. [PMID: 35023765 DOI: 10.1177/09603271211061502] [Reference Citation Analysis]
84 Shiota T, Kawanishi H, Inoue S, Egawa J, Kawaguchi M. Risk factors for bradypnea in a historical cohort of surgical patients receiving fentanyl-based intravenous analgesia. JA Clin Rep 2018;4:46. [PMID: 32025969 DOI: 10.1186/s40981-018-0186-x] [Reference Citation Analysis]
85 Damasceno TA, Scorzoni A Filho, Chahud F, Rodrigues AJ, Vicente WV, Evora PR. Cardiopulmonary Bypass Ischemic Hepatitis Reported in Five Patients. Braz J Cardiovasc Surg 2016;31:330-3. [PMID: 27849307 DOI: 10.5935/1678-9741.20160059] [Reference Citation Analysis]